Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of HKPD will rise by +36.20% over the next 2 Weeks and hit $0.25 by Tuesday, September 15, 2026. In that time frame, HKPD's share price is expected to range between $0.21 and $0.29.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Sep 15, 2026 | 0.21 | 0.25 | 0.29 |
| Sep 14, 2026 | 0.23 | 0.27 | 0.31 |
| Sep 11, 2026 | 0.22 | 0.26 | 0.30 |
| Sep 10, 2026 | 0.22 | 0.26 | 0.31 |
| Sep 9, 2026 | 0.22 | 0.26 | 0.30 |
| Sep 8, 2026 | 0.21 | 0.25 | 0.29 |
| Sep 7, 2026 | 0.23 | 0.27 | 0.31 |
| Sep 4, 2026 | 0.21 | 0.26 | 0.29 |
| Sep 3, 2026 | 0.23 | 0.26 | 0.30 |
| Sep 2, 2026 | 0.22 | 0.26 | 0.30 |
HKPD shares fell -45.54% in Tuesday, September 1, 2026's trading session, dropping from a previous close of $0.33 to move at $0.18. The stock demonstrated notable intraday movement (see HKPD's key stats for a full breakdown), fluctuating between $0.17 and $0.47, a +177.43% trading range. While recent weeks have seen some volatility, HKPD has managed to secure a -53.10% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 97.7M shares changing hands, 97.67M more than the previous session. This amounted to $17.73M in total market activity.
Will HKPD Continue Its Upward Trend?
According to analyst ratings and projections for HKPD, Cellyan Biotechnology Co., Ltd shares are anticipated to increase by +36.66%, potentially reaching $0.29 per share by September 15, 2026. Short-term technical indicators currently suggest a bullish sentiment for HKPD. However, the stock has recorded 18 negative trading days within the past 30 sessions. Based on the HKPD stock forecast, now is a good time to buy HKPD stock because its current trading price is -26.58% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on HKPD covering social and institutional perspectives.
HKPD Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into HKPD's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 17.99% to 29.28%) suggest the stock is in a strong bearish momentum phase. The 50-day RSI, at 38.17%, hints at potential weakness developing in the medium term. Additionally, the 100-day RSI, at 41.74%, maintains a neutral outlook for the long term. Insights into HKPD's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Cellyan Biotechnology Co Short-Term Forecasts
HKPD Forecast For Next 5 Days
Our algorithm anticipates Cellyan Biotechnology Co (HKPD) stock could hit $0.34 by Sep 08, 2026. This represents a +86.61% fall from today's price, following a -0.04% change over the past five days.
HKPD Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Cellyan Biotechnology Co., Ltd (HKPD) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $0.32, which would mean a +76.31% increase from the current price of $0.18. Projections for this period range from a high of $0.39 to a low of $0.23.
HKPD Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Cellyan Biotechnology Co's price over the next three months point to a rise. HKPD stock is expected to peak at $3.39 on Sep 21, 2026 before potentially dipping to $0.38 on Nov 13, 2026. On average, HKPD is likely to trade around $1.92 in the coming 90 days.
Cellyan Biotechnology Co Stock Forecast 2025
Based on our predictive models, Cellyan Biotechnology Co (HKPD) is expected to trade between $0.17 and $3.39 throughout 2026. This would result in an average price of $1.56, potentially offering investors a +759.50% return from current levels.
Cellyan Biotechnology Co., Ltd Monthly Forecast 2026–2027
September 2026
According to our latest forecast models, Cellyan Biotechnology Co., Ltd (HKPD) is positioned to show a strong performance in September 2026. The price is predicted to move between $2.13 and $3.39, settling at an average of $2.90. This could translate to a +1,497.80% gain.
October 2026
Based on current market signals, Cellyan Biotechnology Co., Ltd is projected to trend october 2026. We forecast a trading range from $1.33 to $3.01, with a likely average price of $2.27. Investors could expect a potential return of +1,150.69%.
November 2026
Our predictive algorithms indicate Cellyan Biotechnology Co., Ltd stock may see a shift in November 2026. The expected range spans $0.38–$1.19, with an average target of $0.68. This represents a positive outlook and a possible gain of +274.66%.
December 2026
Analyzing established trends, Cellyan Biotechnology Co., Ltd looks set to move in December 2026. Projections place the stock between $0.17 and $0.78, averaging around $0.47. This suggests a +158.95% gain from current levels.
January 2027
Market indicators suggest Cellyan Biotechnology Co., Ltd could experience notable changes during January 2027. Prices could fluctuate within $0.72 to $1.15, with a midpoint forecast of $0.93. The stock might deliver a +412.40% gain.
February 2027
Forecasting for February 2027, models estimate that Cellyan Biotechnology Co., Ltd may undergo key fluctuations. If trends hold, the stock might trade between $0.84 and $1.29, averaging $1.08. This signals a positive trajectory with potential returns around +495.04%.
March 2027
According to our latest forecast models, Cellyan Biotechnology Co., Ltd (HKPD) is positioned to show a strong performance in March 2027. The price is predicted to move between $0.09 and $0.92, settling at an average of $0.64. This could translate to a +252.62% gain.
April 2027
Based on current market signals, Cellyan Biotechnology Co., Ltd is projected to trend april 2027. We forecast a trading range from $0.00 to $0.48, with a likely average price of $0.16. Investors could expect a potential return of -11.85%.
May 2027
Our predictive algorithms indicate Cellyan Biotechnology Co., Ltd stock may see a shift in May 2027. The expected range spans $0.15–$0.51, with an average target of $0.31. This represents a positive outlook and a possible gain of +70.80%.
June 2027
Analyzing established trends, Cellyan Biotechnology Co., Ltd looks set to move in June 2027. Projections place the stock between $0.15 and $0.50, averaging around $0.31. This suggests a +70.80% gain from current levels.
July 2027
Market indicators suggest Cellyan Biotechnology Co., Ltd could experience notable changes during July 2027. Prices could fluctuate within $0.29 to $0.60, with a midpoint forecast of $0.46. The stock might deliver a +153.44% gain.
August 2027
Forecasting for August 2027, models estimate that Cellyan Biotechnology Co., Ltd may undergo key fluctuations. If trends hold, the stock might trade between $0.10 and $0.50, averaging $0.35. This signals a positive trajectory with potential returns around +92.84%.
September 2027
According to our latest forecast models, Cellyan Biotechnology Co., Ltd (HKPD) is positioned to show a strong performance in September 2027. The price is predicted to move between $0.09 and $0.16, settling at an average of $0.13. This could translate to a -28.37% loss.
HKPD's history of dividends and stock splits also plays a role in long-term investor confidence.